+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      Terikalant and barium decrease the area of vulnerability to ventricular fibrillation induction by T-wave shocks.

      Journal of Cardiovascular Pharmacology
      Action Potentials, drug effects, Animals, Anti-Arrhythmia Agents, pharmacology, Barium Compounds, Chlorides, Chromans, Dogs, Electric Countershock, Electrocardiography, Female, Infusions, Intravenous, Male, Piperidines, Ventricular Fibrillation, etiology, physiopathology, Ventricular Function

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The area of vulnerability (AOV) to ventricular fibrillation (VF) induction by high-voltage shocks has been proposed as a measure of vulnerability to VF. Biphasic shocks spanning the T wave and ranging between 50 V and the upper limit of vulnerability (ULV) to VF were delivered before and after terikalant (1 mg/kg) and barium (1.1 mg/kg load followed by 0.05-0.10 mg/kg/min maintenance) or vehicle in dogs. The AOV decreased by 34% and 28% (p < 0.01) after terikalant and barium (n = 8 dogs each), respectively. Mean ULV, defibrillation threshold (DFT), and ventricular vulnerability period (VVP) decreased by 16%, 23%, and 31% (p < 0.01), respectively, after terikalant, and by 25%, 17% (p < 0.01), and 13% (p = 0.08), respectively, after barium. Vehicle (n = 14) did not significantly alter any of these variables. The ULV was correlated with the DFT before and after terikalant (r = 0.78, p < 0.01) and barium (r = 0.83, p < 0.01). Potassium channel blockers of the current reduce the ability to induce VF; this effect may be related to the anti-fibrillatory action of class III anti-arrhythmic drugs and their ability to decrease DFT.

          Related collections

          Author and article information


          Comment on this article